YODA Project

Yale University Open Data Access (YODA) Project

Press

"Secret Clinical Trial Data to Go Public" (Scientific American, June 1, 2014)

"Sharing the Wealth" (TheScientist, May 1, 2014)

"Prof. pushes for release of Vioxx documents" (The Brown Daily Herald, April 7, 2014)

"Whose data is it, anyway?" (YaleMedicine, March 13, 2014)

"Straight Talk With...Harlan Krumholz" (Nature Medicine, March 4, 2014)

J&J puts trial data in independent hands” (chemistryworld, February 4, 2014)

Give the Data to the People” (New York Times, February 3, 2014)

"J&J to allow access to clinical research through Yale open-data project" (Modern Healthcare, January 30, 2014)

Yale program’s agreement with Johnson & Johnson allows broad access to clinical trial data” (Yale News, January 30, 2014)

Johnson & Johnson Announces Clinical Trial Data Sharing Agreement with Yale School of Medicine” (Johnson & Johnson, January 30, 2014)

Johnson & Johnson Will Share Clinical Trial Data” (Forbes, January 30, 2014)

In Stunning Win For Open Science, Johnson & Johnson Decides To Release Its Clinical Trial Data To Researchers” (Forbes, January 30, 2014)

J&J chooses Yale to review requests for clinical drug data” (Reuters, January 30, 2014)

J&J to Share Drug Research Data in Pact With Yale” (Wall Street Journal, January 30, 2014)

J&J Sets Drug Data Free in ‘YODA’ Collaboration With Yale” (Bloomberg, January 30, 2014)

J&J’s Clinical Data Disclosure Strategy Focuses On Collaboration With Yale University Group” (Informa, January 30, 2014)

J&J Opens Data Vault to Yale, in ‘Unprecedented’ Transparency Move” (Xconomy, January 30, 2014)

Medtronic's Infuse No Better than Bone Graft with More Risk”(Bloomberg Businessweek, June 18, 2013)

Long-awaited Yale Study Raises Questions about Integrity of Previous Studies of Medtronic's Infuse ” (Minneapolis Star Tribune, June 18, 2013)

Safety Review of Bone Growth Product Ushers in New Era of Data Sharing” (Yale News, June 17, 2013)

"Outside Review of Clinical Data Find a Spinal Treatment's Benefit Overstated” (New York Times, June 17, 2013)

Studies Fail to Back Medtronic Drug Claims ” (Wall Street Journal, June 17, 2013)

Medtronic Bone Graft has Limited Benefit, May Cause Harm- Reviews” (Reuters, June 17, 2013)

Data Reviews Question Use of rhBMP-2 in Spinal Fusion (Medscape, June 17, 2013)

Report Deals Another Blow to Synthetic Bone Growth Product” (Stanford Medicine, June 17, 2013)


Publications